Abstract
Coronary heart disease (CHD) remains the leading cause of death in many countries. The fact that it may be declining in some areas (e.g. United States, Australia) allows no grounds for complacency. It is estimated that still more than 1.25 million Americans suffer a heart attack each year (Levy 1981), and in Scotland in 1977 the death rate from coronary disease was 800 per 100 000 population.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Committee of principal investigators (1978) A co-operative trial in the prevention of ischaemic heart disease using clofibrate. Br Heart J 40: 1069
Duffield RGM, Lewis B, Miller NE, Jameson CE, Brunt JNH, Colchester ACF (1983) Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. Lancet II:639–642
Editorial (1975) Lipids and ischaemic heart disease. Lancet II: 398
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 34
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 94
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 148
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 215
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 272
Gordon T, Castelli WP, Mjortland MC, Kannel WB, Dawber TR (1977) Predicting coronary disease in middle-aged and older persons. The Framingham Study. JAMA 238: 497
Hjermann I, Velve Byre K, Holme I, Leren P (1981) Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet II: 1303–1310
Levy RI (1981) Lipoproteins, apoproteins and heart disease. Present status and future prospects. Clin Chem Acta 27: 653
Miller GJ, Miller NE (1975) Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet I: 16
MRFIT Research Group (1982) Multiple risk factor intervention trial: risk factor changes and mortalitiy results. JAMA 248: 1465–1477
Murray RG, Tweddel A, Third JLHC, Hillis WS, Hutton I, Lorimer AR, Lawrie TDV (1975) Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J 37: 1035
Olsson AG, Carlson LA, Erikson U, Helmius G, Hemmingsson A, Ruhn G (1982) Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia. Lancet I: 1311
Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 420
The Lipid Research Clinics Coronary Primary Prevention Trial Results (1984) I. Reduction in incidence of coronary heart disease. JAMA 251: 351
The Lipid Research Clinics Coronary Primary Prevention Trial Results (1984) II. The relation of reduction in incidence of coronary heart disease to cholesterol. JAMA 251: 365
WHO European Collaborative Group (1983) Multifactorial trial in the prevention of coronary heart disease. 3. Incidence and mortality results. Eur Heart J 4: 141–147
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lorimer, A.R., Hillis, W.S. (1985). Atherosclerosis and Hyperlipoproteinaemia. In: Cardiovascular Disease. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3120-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3120-5_2
Publisher Name: Springer, London
Print ISBN: 978-3-540-15426-6
Online ISBN: 978-1-4471-3120-5
eBook Packages: Springer Book Archive